State of lab market 2024

In this episode, Melissa Butterworth discusses the state of the lab market in 2024. She highlights two major trends: larger transactions and hospital outreach transactions. She also mentions the continued interest and deals in the pathology space and the positive sign of mid-sized clinical lab transactions. Melissa provides insights into the multiples for pathology and clinical laboratory deals and emphasizes the importance of having a M&A advisor. Overall, she concludes that it is a positive time for lab owners considering exiting the space.